LINC01610 and adenocarcinoma: Regardless of a biological function, the specificity of EVADR activation in adenocarcinomas coupled with the poorer survival probability that tracks with elevated EVADR expression suggested that further characterization of EVADR as a candidate adenocarcinoma biomarker is warranted [42].